[Glucose-6-phosphate dehydrogenase deficiency in children: a case report]

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common red blood cell enzyme disorder, can cause hemolytic crisis after fava bean ingestion. This case highlights the varied clinical presentations of G6PD deficiency, emphasizing its importance in diagnosing hemolytic anemia.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most prevalent red blood cell enzyme disorder globally.
  • Reduced G6PD activity elevates red blood cell susceptibility to oxidative stress, triggered by factors like fava beans or certain medications.
  • Clinical manifestations range from acute hemolysis and chronic hemolysis to neonatal hyperbilirubinemia and asymptomatic cases.

Observation:

  • A 2-year-old boy experienced a severe hemolytic crisis following fava bean consumption.
  • The child had a history of unexplained neonatal jaundice and required red blood cell transfusion due to anemia.
  • No family history of hemolytic anemia or parental consanguinity was reported.

Findings:

  • Qualitative G6PD testing confirmed enzyme deficiency in the patient.
  • The clinical presentation, triggered by favism, led to acute hemolytic anemia.
  • The case underscores the diagnostic challenge posed by G6PD deficiency's variable clinical spectrum.

Implications:

  • G6PD deficiency diagnosis is crucial for managing hemolytic anemia across all age groups.
  • Awareness of G6PD deficiency's diverse presentations is essential for timely and accurate diagnosis.
  • Prompt identification and avoidance of triggers like fava beans can prevent severe hemolytic episodes.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
157.6K
Glycolysis: Preparatory Phase01:21

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy),  glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
10.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.3K